Amethyst Austria and IASO-Health GmbH Announce New Partnership

IASO-Health-GmbH-and-Amethyst-Austria-Partner

Vienna, Austria / Bad Ragaz, Switzerland – July 16, 2025

Amethyst Healthcare is excited to announce an exclusive collaboration with IASO‑Health GmbH, led by CEO & Founder Bruno Rosset. This partnership grants IASO‑Health patients’ direct access to Amethyst Radiotherapy’s state-of-the-art center within the prestigious Wiener Privatklinik in Vienna.

Cutting‑Edge Radiotherapy in Austria

Amethyst Radiotherapy Vienna is powered by the Elekta Versa HD linear accelerator, renowned for its precision and versatility. The center offers advanced radiation modalities, including:

  • External Beam Radiation via Linac, delivering high‑energy X‑rays and electrons
  • Intensity-Modulated Radiotherapy (IMRT)
  • Volumetric Modulated Arc Therapy (VMAT)
  • Stereotactic Radiosurgery (SRS/SRT) for highly targeted, millimeter‑precise tumour

 

Equipped with Cone-Beam CT, multileaf collimators (MLC), HexaPOD couch with six degrees of freedom, and in‑vivo dose monitoring, the centre ensures maximum tumour targeting with minimal impact on healthy tissue

 

Under this collaboration, IASO‑Health patients, supported by its renowned integrative care, including dendritic cell immunotherapy, will benefit from prioritised access to Amethyst’s Vienna centre’s appointments, streamlined pathways across Switzerland, Germany, and Austria, and a highly coordinated treatment journey.

 

Bruno Rosset, CEO & Founder of IASO‑Health comments: “Partnering with Amethyst Healthcare enables us to integrate world‑class radiotherapy with our innovative immunotherapy approaches, ensuring our patients benefit from both cutting‑edge technology and deeply personalised care.”

 

Paul Stuchetz, Managing Director, Amethyst Radiotherapy Austria, adds: “Since opening in October 2020, our centre has delivered precision cancer care. This partnership with IASO‑Health strengthens patient access to rapid, high‑quality treatment in Vienna.

 

Dr. David Kuczer, Partner Radiation Oncologist at Amethyst Radiotherapy Austria, Clinical Lead at Amethyst Radiotherapy Austria, states: “With millimetre-level accuracy in stereotactic treatments and robust IMRT/VMAT protocols, this collaboration empowers patients with seamless access to our non‑invasive, high‑precision therapies, backed by comprehensive support systems”.

 

<< ENDS >>

 

For media inquiries, please contact: [email protected]